VRNA veronapharma.com Revenue Growth QoQ

Official company branding of Verona Pharma plc (VRNA)

The quarterly revenue growth trend demonstrates how the indicator value reaches 0.00. This positive momentum is driven by the product launch stage and the exclusive right to determine therapy pricing. FDA protection against drug copying and patent purity ensure high profitability. Consequently, Verona Pharma plc (VRNA) is strengthening its status as an authoritative developer in the treatment of respiratory pathologies.

VRNA Verona Pharma Corp Quarterly Revenue Growth Rate (07/04/2022 - 10/18/2025)

Summary analytical data breakdowns for Verona Pharma Corp (VRNA)

- stock price and consensus target price:
- cash balance and cash flow data:
General company analysis:VRNA - Verona Pharma Corp
Manufactured products of Verona Pharma PLC

Fundamental revenue analysis allows investors to minimize risks by identifying the actual trajectory of business development. For Verona Pharma plc (VRNA), the effectiveness of ESG strategies and the optimization of drug supply chains must translate into actual cash flow. This quarterly revenue trend metric measures the percentage change in income over three months relative to the previous period. A stable growth trend confirms the company's capitalization and the resilience of its market positions.

Key competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Jyong Bio (MENS) - Revenue Growth QoQ|Revenue Change vs Previous Quarter Ligand LGND|AMRX (amneal.com) - Quarterly Revenue Growth|PRGO: Quarterly Revenue Increase|Quarterly Sales Growth ALVO (Alvotech Corp)|Quarterly Sales Growth Rate Liquidia Corporation|Quarterly Revenue Growth GLPG (glpg.com)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)